Used as a key intermediate in the synthesis of fluorinated pharmaceuticals, particularly in the development of selective enzyme inhibitors and central nervous system agents. Its structure supports enhanced metabolic stability and binding affinity in drug candidates. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) requiring fluorinated aromatic motifs, especially in oncology and neurology research. Also utilized in agrochemicals for designing bioactive molecules with improved lipophilicity and membrane permeability.